|
|
||||||||
Papers In Press, published online ahead of print August 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Metabolism Section/Medicine, University of California, San Francisco, San Francisco, CA 94121
Corresponding Author: grunfld{at}itsa.ucsf.edu
Fatty acid oxidation provides energy in tissues with high metabolic demands. During the acute phase response (APR) induced by infection and inflammation, fatty acid oxidation is decreased associated with hypertriglyceridemia. Little is known about the mechanism by which the APR decreases fatty acid oxidation. Therefore, we investigated whether the APR affects the expression of medium-chain acyl CoA dehydrogenase (MCAD), its regulator the estrogen-related receptor a (ERRa) and a key coactivator of ERRa, the peroxisome proliferator-activated receptor coactivator-1a (PGC-1a). mRNA levels of PGC-1a, ERRa and MCAD are markedly reduced in the liver, heart and kidney of mice during the LPS-induced APR. The decreases were rapid and occurred at very low doses of LPS. MCAD activity in liver was also reduced. Furthermore, binding of hepatic nuclear extracts to the ERRa-response element found in the promoter region of MCAD was significantly decreased during the APR, suggesting the decreased transcription of the MCAD gene. The binding activity was identified as ERRa by supershift with antibody to ERRa. Similar decreases in mRNA levels of these genes occur during zymosan and turpentine induced inflammation, indicating that suppression of PGC-1a, ERRa, and MCAD pathway is a general response during infection and inflammation. Our study provides a potential mechanism by which the APR decreases fatty acid oxidation.
Accepted on July 26, 2005
Suppression of estrogen-related receptor-
and medium-chain acyl coenzyme A dehydrogenase in the acute phase response
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Giguere Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors Endocr. Rev., October 1, 2008; 29(6): 677 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Marriott, K. R. McGann-Gramling, B. Hauss-Wegrzyniak, L. C. Sheldahl, R. A. Shapiro, D. M. Dorsa, and G. L. Wenk Brain Infusion of Lipopolysaccharide Increases Uterine Growth as a Function of Estrogen Replacement Regimen: Suppression of Uterine Estrogen Receptor-{alpha} by Constant, But Not Pulsed, Estrogen Replacement Endocrinology, January 1, 2007; 148(1): 232 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lu, A. H. Moser, J. K. Shigenaga, K. R. Feingold, and C. Grunfeld Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response J. Lipid Res., October 1, 2006; 47(10): 2179 - 2190. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |